Biomics

Bronchial asthma is one of the most common chronic respiratory diseases. Histamine is a central mediator of inflammation which plays an important role in airway obstruction and bronchial secretion. Epigenetic studies of asthma patients confirm the association between the epigenetic regulation of gene expression and the pathogenesis of this disease. In recent years, an increasing number of differentially methylated CpG sites associated with the risk of asthma development and clinical course was identified. The aim of this work was to carry out a comparative analysis of the degree of methylation of the histamine receptor genes HRH1 and HRH2 promoter regions between with asthma patients and individuals of the control group from the Republic of Bashkortostan (RB). DNA samples isolated from the peripheral blood of 157 asthma patients and 155 controls under 18 years of age of Russian and Tatar ethnicity were used as the study material. MS-HRM analysis of the promoter region of the histamine receptor H1 gene HRH1 showed that the methylation level of this region varies from 90% to 100%. A significantly higher frequency of complete methylation (100%) of the promoter region of the HRH1 gene was found in patients with asthma compared to controls. MS-HRM analysis of the promoter region of the histamine receptor H2 gene HRH2 showed that the methylation level of this region was from 0% to 10%; no significant differences in the frequency of different methylation levels in asthma children and individuals from the control group were found. Thus, differential methylation of the promoter region of the HRH1 gene between asthma patients and controls was found confirming the involvement of the epigenetic mechanism of DNA methylation in the disease pathogenesis.

bronchial asthma, histamine, DNA methylation, promoter region

1. Cardenas A., Sordillo J. E., Rifas-Shiman S. L. et al. The nasal methylome as a biomarker of asthma and airway inflammation in children. Nat Commun. 2019. V. 10. P. 3095. doi:10.1038/s41467-019-11058-3

2. Gautam Y., Johansson E., Mersha T.B. MultiOmics Profiling Approach to Asthma: An Evolving Paradigm. J Pers Med. 2022; 12(1): 66. doi: 10.3390/jpm12010066

3. Forno E.,Zhang R., Jiang Y. et al. Transcriptomewide and differential expression network analyses of childhood asthma in nasal epithelium. J Allergy Clin Immunol. 2020. V. 146 (3). P. 671-675. doi: 10.1016/j.jaci.2020.02.005

4. Kordulewska N., Cieslinska A., Fiedorowicz E. et al. Effect of the fexofenadine on the expression of HRH-1 and HRH-4 receptor in peripheral blood mononuclear cell isolated from children with diagnosed allergy - in vitro study short communication. Pharm. Pharm. Sci. 2019. V. 22 (1). P. 93-97. doi: 10.18433/jpps29971

5. Micallef S., Sasse A. Genetic polymorphisms in the histamine receptor family. Histamine Receptors. In: Blandina P., Passani M. B. Histamine Receptors - Preclinical and Clinical Aspects. Switzerland: Humana Press, Springer Nature. 2016. P. 51-74. doi 10.1007/978-3-319-40308-3_2

6. Nicodemus-Johnson J., Myers R. A., Sakabe N. J. et al. DNA methylation in lung cells is associated with asthma endotypes and genetic risk. JCI Insight. 2016. V. 1. P. e90151.doi: 10.1172/jci.insight.90151 

7. Savelieva O.N., Karunas A.S., Fedorova Yu.Yu., Khusnutdinova E.K. Pharmacogenetics of asthma. Medical Genetics. 2019;18(4):3-23. doi: 10.25557/2073-7998.2019.04 (In Russ.)

8. Sobkowiak P., Langwiński W., Nowakowska J. et al. Neuroinflammatory Gene Expression Pattern Is Similar between Allergic Rhinitis and Atopic Dermatitis but Distinct from Atopic Asthma. BioMed Research International. 2020. V. 2020. P. 1-10. doi: 10.1155/2020/7196981

9. Wasti B., Liu S., Xiang X-D. Role of Epigenetics in the Pathogenesis, Treatment, Prediction, and Cellular Transformation of Asthma. Mediators Inflamm. 2021. 9412929. doi: 10.1155/2021/9412929